Skip to main content
. Author manuscript; available in PMC: 2012 May 1.
Published in final edited form as: Nutr Cancer. 2011 May;63(4):573–582. doi: 10.1080/01635581.2011.553022

Table 3.

Associations Between Specialty Supplements and Prostate Cancer Defined by Grade Among Male VITAL Participants, 2004–2007 (n=34,608).

Low-Grade Cases
(n = 750)
High-Grade Cases
(n = 221)
Non-Cases
(n = 33,637)
Low-Grade High-Grade
Supplement No. % No. % No. % HRa 95% CI HRa 95% CI
Coenzyme Q10
      Non-User 712 94.93 206 93.21 31,828 94.82 1.00 Referent 1.00 Referent
      User 38 5.07 15 6.79 1,737 5.18 0.94 0.67, 1.32 1.08 0.60, 1.95
      P-heterogeneity 0.70
Fish Oilb
      Non-User 683 91.07 199 90.05 30,629 91.27 1.00 Referent 1.00 Referent
      User 67 8.93 22 9.95 2,928 8.73 0.96 0.73, 1.25 1.04 0.65, 1.69
      P-heterogeneity 0.93
Garlic Pills
      Non-User 659 87.87 195 88.24 29,970 89.35 1.00 Referent 1.00 Referent
      User 91 12.13 26 11.76 3,572 10.65 1.10 0.87, 1.38 0.98 0.63, 1.52
      P-heterogeneity 0.68
Ginkgo Bilobac
      Non-User 668 89.07 196 89.09 30,318 90.38 1.00 Referent 1.00 Referent
      User 82 10.93 24 10.91 3,226 9.62 1.15 0.90, 1.46 1.16 0.74, 1.82
      P-heterogeneity 0.97
Ginseng
      Non-User 715 95.33 211 95.91 31,731 94.57 1.00 Referent 1.00 Referent
      User 35 4.67 9 4.09 1,821 5.43 0.89 0.62, 1.27 0.80 0.39, 1.63
      P-heterogeneity 0.69
Grapeseedb
      Non-User 735 98.13 214 97.27 32,609 97.11 1.00 Referent 1.00 Referent
      User 14 1.87 6 2.73 971 2.89 0.58 0.33, 1.03 0.82 0.34, 2.00
      P-heterogeneity 0.58
Glucosamineb
      Non-User 622 82.93 181 81.90 28,187 83.97 1.00 Referent 1.00 Referent
      User 128 17.07 40 18.10 5,380 16.03 0.97 0.79, 1.19 1.06 0.73, 1.54
      P-heterogeneity 0.53
Chondroitinb
      Non-User 667 88.93 199 90.05 30,064 89.54 1.00 Referent 1.00 Referent
      User 83 11.07 22 9.95 3,511 10.46 0.93 0.73, 1.19 0.82 0.51, 1.31
      P-heterogeneity 0.74
Saw Palmetto
      Non-User 644 85.98 196 89.09 30,159 89.84 1.00 Referent 1.00 Referent
      User 105 14.02 23 10.91 3,412 10.16 1.16 0.93, 1.45 0.91 0.58, 1.43
      P-heterogeneity 0.34

Abbreviations: HR, Hazards Ratio; CI, Confidence Interval

a

Adjusted for age, race, education, body mass index, multivitamin use, PSA test, benign prostate biopsy, enlarged prostate, family history of prostate cancer, and diabetes

b

Additionally adjusted for coronary artery disease (fish oil, grapeseed), memory loss (fish oil, ginkgo biloba), osteoarthritis (glucosamine, chondroitin), chronic joint pain (glucosamine, chondroitin)